thiosulfates has been researched along with Pancreatic Neoplasms in 2 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with carcinomatous peritonitis of gastrointestinal cancer have been treated with administrations of CDDP-Ip (50-150 mg/body), in combination with systemic chemotherapy simultaneously combined with sodium thiosulfate (STS) iv in 4 patients." | 1.27 | [Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics]. ( Fukushi, A; Hirayama, M; Koda, K; Kure, T; Morita, K; Nakazawa, O; Takahashi, H; Terada, S; Terui, T; Yoshizaki, N, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawkes, JE | 1 |
| Karavan, M | 1 |
| Bowen, AR | 1 |
| Summers, EM | 1 |
| Koda, K | 1 |
| Nakazawa, O | 1 |
| Terada, S | 1 |
| Kure, T | 1 |
| Morita, K | 1 |
| Hirayama, M | 1 |
| Fukushi, A | 1 |
| Terui, T | 1 |
| Yoshizaki, N | 1 |
| Takahashi, H | 1 |
2 other studies available for thiosulfates and Pancreatic Neoplasms
| Article | Year |
|---|---|
Nonuraemic calciphylaxis and pancreatic cancer: a previously unreported association.
Topics: Adenocarcinoma; Administration, Oral; Aged; Calciphylaxis; Chelating Agents; Fatal Outcome; Humans; | 2014 |
[Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; D | 1988 |